A CXCR4-targeted immunomodulatory nanomedicine for photodynamic amplified immune checkpoint blockade therapy against breast cancer

Journal:

Acta Biomaterialia

Published:

2025-05-01

DOI:

10.1016/j.actbio.2025.03.049

Affiliations:

3

Authors:

8

Go to article

Institutions	Authors	Share
The Fifth Affiliated Hospital, GMU, China	5.000000	0.63
Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, SCAU, China	2.000000	0.25
Guangdong Pharmaceutical University (GDPU), China	1.000000	0.13

Interested in Oncology and Carcinogenesis?